ABXL Q1 2026 Earnings EPS Just Below Estimates Amid Stable Operations CIEN Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss GATX Q1 2026 Earnings EPS Slightly Beats Estimates Amid Cautious Market Response STAG Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage